Health Catalyst (HCAT): General Counsel had shares withheld for tax 21K shares

21K

Shares · @ $1.66

Traded

Mar 2, 2026

Filed

Mar 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jan 12, 2026Company filing · Form 8-K · ResultsReported its results
2. Jan 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On January 20, 2026, the Board of Directors of Health Catalyst, Inc. (the Company) determined that Kevin Freeman will cease to serve as the Chief Commercial Officer of the Company on February 1, 2026.”
3. Feb 12, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 12, 2026, the Board of Directors (the Board) of Health Catalyst, Inc. (the Company) appointed Ben Albert to succeed Mr. Burton as the Company’s Chief Executive Officer and principal executive officer, effective February 12, 2026.”

What came next

1. Mar 12, 2026Company filing · Form 8-K · ResultsReported its results
2. Mar 31, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“As previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on February 18, 2026, on February 12, 2026, Daniel Burton informed the Board of Directors of Health Catalyst, Inc. (the Company) of the acceleration of the effective date of his retirement from his position as Chief Executive Officer and principal executive officer of the Company to February 12, 2026.”
3. Apr 24, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On April 24, 2026, the Board of Directors (our Board) of Health Catalyst, Inc. (the Company) determined that Linda Llewelyn will cease to serve as the Chief People Officer of the Company effective June 1, 2026 due to the elimination of the Chief People Officer role in connection with the workforce reduction described in this Current Report on Form 8-K. In order to enable a smooth transition of her prior…”
4. Apr 29, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On April 29, 2026, the board of directors (our Board) of Health Catalyst, Inc. (the Company), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Steven Nelson to the Board, effective May 1, 2026.”
5. May 11, 2026Company filing · Form 8-K · ResultsReported its results
6. Jun 4, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Health Catalyst

For Health Catalyst, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCAT page.

Other recent filings by Benjamin Landry, General Counsel

• SEC Form 4 at Health Catalyst (HCAT)Nov 13, 2026
• SEC Form 4 at Health Catalyst (HCAT)Nov 13, 2026
• SEC Form 4 at Health Catalyst (HCAT)Dec 10, 2025
• SEC Form 4 at Health Catalyst (HCAT)Sep 9, 2025
• SEC Form 4 at Health Catalyst (HCAT)Jun 9, 2025

The full history of Benjamin Landry, General Counsel is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Health Catalyst

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 144Nov 12, 2026
• SEC Form 144Nov 11, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 4Dec 10, 2025

Everything OQRO holds on this company is on its HCAT page.